| Primary |
| Diabetes Mellitus |
37.2% |
| Type 2 Diabetes Mellitus |
18.2% |
| Diabetes Mellitus Non-insulin-dependent |
10.9% |
| Hypertension |
5.8% |
| Depression |
4.3% |
| Hiv Test Positive |
3.1% |
| Diabetes Mellitus Management |
2.3% |
| Diabetes Mellitus Inadequate Control |
1.9% |
| Intentional Self-injury |
1.9% |
| Atrial Fibrillation |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Essential Hypertension |
1.6% |
| Multiple Sclerosis |
1.6% |
| Osteoarthritis |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Fatigue |
1.2% |
| Incontinence |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Abdominal Exploration |
0.8% |
| Bronchopneumonia |
0.8% |
|
| Death |
18.6% |
| Blood Glucose Increased |
10.6% |
| Drug Ineffective |
9.9% |
| Hypoglycaemia |
9.9% |
| Nausea |
6.2% |
| Renal Failure Acute |
5.0% |
| Diarrhoea |
4.3% |
| Pharmaceutical Product Complaint |
3.7% |
| Rash |
3.7% |
| Weight Decreased |
3.7% |
| Blood Glucose Fluctuation |
3.1% |
| Malaise |
3.1% |
| Myocardial Infarction |
3.1% |
| Syncope |
3.1% |
| Weight Increased |
2.5% |
| Diabetes Mellitus Inadequate Control |
1.9% |
| Hypoglycaemic Coma |
1.9% |
| Medication Error |
1.9% |
| Metabolic Acidosis |
1.9% |
| Poisoning |
1.9% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
14.0% |
| Diabetes Mellitus |
13.5% |
| Hiv Infection |
10.4% |
| Product Used For Unknown Indication |
9.9% |
| Depression |
8.2% |
| Multiple Sclerosis |
7.0% |
| Drug Use For Unknown Indication |
6.0% |
| Diabetes Mellitus Non-insulin-dependent |
5.5% |
| Blood Cholesterol Increased |
4.6% |
| Fatigue |
3.6% |
| Pulmonary Hypertension |
2.7% |
| Pain |
2.4% |
| Incontinence |
2.2% |
| Anxiety |
1.9% |
| Hypertension |
1.9% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.9% |
| Drug Exposure During Pregnancy |
1.4% |
| Dyslipidaemia |
1.0% |
| Hiv Test Positive |
1.0% |
| Insulin Resistance |
1.0% |
|
| Talipes |
12.1% |
| Weight Increased |
11.0% |
| Hypoglycaemia |
7.7% |
| Drug Ineffective |
5.5% |
| Hepatic Cirrhosis |
5.5% |
| Pancreatitis Chronic |
5.5% |
| Ventricular Arrhythmia |
5.5% |
| Weight Decreased |
5.5% |
| Blood Glucose Decreased |
4.4% |
| Death |
4.4% |
| Loss Of Consciousness |
4.4% |
| Photosensitivity Reaction |
4.4% |
| Premature Labour |
4.4% |
| Myalgia |
3.3% |
| Pharmaceutical Product Complaint |
3.3% |
| Self-medication |
3.3% |
| Vacterl Syndrome |
3.3% |
| Blood Glucose Fluctuation |
2.2% |
| Cardiovascular Disorder |
2.2% |
| Diarrhoea |
2.2% |
|
| Concomitant |
| Diabetes Mellitus |
18.4% |
| Type 2 Diabetes Mellitus |
15.1% |
| Diabetes Mellitus Non-insulin-dependent |
14.8% |
| Product Used For Unknown Indication |
9.7% |
| Hypertension |
9.2% |
| Drug Use For Unknown Indication |
6.8% |
| Depression |
3.5% |
| Breast Cancer |
3.1% |
| Pain |
2.7% |
| Blood Cholesterol Increased |
2.4% |
| Prophylaxis |
1.9% |
| Metastases To Bone |
1.7% |
| Anxiety |
1.7% |
| Asthma |
1.5% |
| Blood Pressure |
1.4% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Blood Cholesterol |
1.2% |
| Arthritis |
1.2% |
| Insomnia |
1.2% |
| Cardiac Disorder |
1.1% |
|
| Weight Decreased |
29.3% |
| Blood Glucose Increased |
10.5% |
| Vomiting |
10.0% |
| Nausea |
7.4% |
| Myocardial Infarction |
7.2% |
| Weight Increased |
6.0% |
| Tremor |
3.8% |
| Type 2 Diabetes Mellitus |
3.1% |
| Pain |
2.5% |
| Transient Ischaemic Attack |
2.5% |
| Pancreatitis |
2.3% |
| Urinary Tract Infection |
2.3% |
| Vision Blurred |
2.1% |
| Drug Ineffective |
2.0% |
| Myocardial Ischaemia |
1.8% |
| Cardiac Failure Congestive |
1.5% |
| Cerebrovascular Accident |
1.5% |
| Injection Site Pain |
1.4% |
| Somnolence |
1.4% |
| Syncope |
1.3% |
|
| Interacting |
| Diabetes Mellitus |
43.8% |
| Hypertension |
18.8% |
| Acute Pulmonary Oedema |
12.5% |
| Cardiac Failure |
12.5% |
| Prophylaxis |
6.3% |
| Type 2 Diabetes Mellitus |
6.3% |
|
| Lactic Acidosis |
25.0% |
| Renal Failure Acute |
25.0% |
| Syncope |
25.0% |
| Volume Blood Decreased |
25.0% |
|
